Add to ORKGrandomised controlled trial of a psycho-assessment at 12 months is planned. The primary outcome is fear of new or recurrent melanoma, as assessed by the Fear of Cancer Recurrence Inventory (FCRI). Secondary outcomes include anxiety, depression, unmet supportive e. educational high risk o
BACKGROUND: People with a melanoma diagnosis are at risk of recurrence, developing a new primary or ...
BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin se...
Malignant melanoma; diagnosis stages using standard anxiety measurement scales and a study specific ...
Background: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
BACKGROUND: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
Purpose People with a history of melanoma commonly report a fear of cancer recurrence (FCR), yet psy...
Objective: To estimate the amount of fear of new or recurrent melanoma among people treated for loca...
This study aimed to evaluate the cost effectiveness of a newly developed psycho-educational interven...
Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and impr...
Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clini...
Purpose: To quantify the prevalence of anxiety or depression (overall; melanoma-related) among peopl...
INTRODUCTION: Psychological support programmes are not currently funded for people with a history of...
Guidelines for evidence-based follow-up in melanoma patients are not available. This study examined ...
Item does not contain fulltextPurpose Fear of cancer recurrence (FCR) is prevalent, distressing, and...
The number of people diagnosed with cancer is steadily increasing while medical advancements have si...
BACKGROUND: People with a melanoma diagnosis are at risk of recurrence, developing a new primary or ...
BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin se...
Malignant melanoma; diagnosis stages using standard anxiety measurement scales and a study specific ...
Background: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
BACKGROUND: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
Purpose People with a history of melanoma commonly report a fear of cancer recurrence (FCR), yet psy...
Objective: To estimate the amount of fear of new or recurrent melanoma among people treated for loca...
This study aimed to evaluate the cost effectiveness of a newly developed psycho-educational interven...
Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and impr...
Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clini...
Purpose: To quantify the prevalence of anxiety or depression (overall; melanoma-related) among peopl...
INTRODUCTION: Psychological support programmes are not currently funded for people with a history of...
Guidelines for evidence-based follow-up in melanoma patients are not available. This study examined ...
Item does not contain fulltextPurpose Fear of cancer recurrence (FCR) is prevalent, distressing, and...
The number of people diagnosed with cancer is steadily increasing while medical advancements have si...
BACKGROUND: People with a melanoma diagnosis are at risk of recurrence, developing a new primary or ...
BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin se...
Malignant melanoma; diagnosis stages using standard anxiety measurement scales and a study specific ...